Literature DB >> 23346180

Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis.

Nicholas George Zaorsky1, Ninad Patil, Gary Mitchel Freedman, Madalina Tuluc.   

Abstract

On a pathological specimen of breast cancer cells, retraction artifact during histological processing mimics true lymphovascular invasion (LVI). The accurate determination of the presence or absence of LVI is a factor in determining risk of having a positive sentinel node, or having additional positive axillary nodes after a positive sentinel node biopsy in women with early-stage breast cancer. The determination of nodal risk influences the decision of the treating physicians as to whether a sentinel node biopsy or completion axillary dissection is necessary. On slide preparation, ideal factors favoring true LVI include: a definite endothelial lining, with endothelial nuclei that seem to protrude into the lymphatic space; invasion in one lymphatic vessel (LV) lumen with nearby cancer glands that have minimal or no retraction; a tumor embolus in a LV clear lumen with outside nearby tumor bulk; a tumor embolus that is different in shape than its surrounding clear LV space; and a positive stain for fibrin, CD31, or CD34 on tumor embolus periphery.

Entities:  

Keywords:  Breast neoplasms; Diagnosis; Pathology

Year:  2012        PMID: 23346180      PMCID: PMC3542859          DOI: 10.4048/jbc.2012.15.4.478

Source DB:  PubMed          Journal:  J Breast Cancer        ISSN: 1738-6756            Impact factor:   3.588


  12 in total

1.  Artefact as the pathologist's friend: peritumoral retraction in in situ and infiltrating duct carcinoma of the breast.

Authors:  Junji Irie; Varsha Manucha; Olga B Ioffe; Steven G Silverberg
Journal:  Int J Surg Pathol       Date:  2007-01       Impact factor: 1.271

2.  The application of immunohistochemical stains to identify endothelial-lined channels in mammary carcinoma.

Authors:  P E Saigo; P P Rosen
Journal:  Cancer       Date:  1987-01-01       Impact factor: 6.860

3.  Intramammary lymphatic invasion in breast carcinomas. Evaluation using ABH isoantigens as endothelial markers.

Authors:  A K Lee; R A DeLellis; H J Wolfe
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

4.  Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.

Authors:  Geza Acs; Kimberly L Dumoff; Lawrence J Solin; Theresa Pasha; Xiaowei Xu; Paul J Zhang
Journal:  Am J Surg Pathol       Date:  2007-01       Impact factor: 6.394

5.  Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance.

Authors:  P P Rosen
Journal:  Pathol Annu       Date:  1983

6.  D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.

Authors:  Shuyue Ren; Mohammed Abuel-Haija; Jasvir S Khurana; Xinmin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2011-01-30

7.  Immunostaining of Type IV Collagen and Smooth Muscle Actin as an Aid in the Diagnosis of Breast Lesions.

Authors:  Shikha Bose; Carolyn M. Derosa; Luciano Ozzello
Journal:  Breast J       Date:  1999-05       Impact factor: 2.431

8.  Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast.

Authors:  M L Prasad; E Hyjek; D D Giri; L Ying; J J O'Leary; S A Hoda
Journal:  Am J Surg Pathol       Date:  1999-02       Impact factor: 6.394

9.  Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.

Authors:  José Luiz B Bevilacqua; Michael W Kattan; Jane V Fey; Hiram S Cody; Patrick I Borgen; Kimberly J Van Zee
Journal:  J Clin Oncol       Date:  2007-07-30       Impact factor: 44.544

10.  Interobserver variation in the identification of breast carcinoma in intramammary lymphatics.

Authors:  K W Gilchrist; V E Gould; S Hirschl; J E Imbriglia; A S Patchefsky; D W Penner; J Pickren; I S Schwartz; J E Wheeler; J M Barnes; E G Mansour
Journal:  Hum Pathol       Date:  1982-02       Impact factor: 3.466

View more
  5 in total

1.  Prognostic significance of lymphovascular space invasion in epithelial ovarian cancer.

Authors:  Ming Chen; Ying Jin; Yalan Bi; Yan Li; Ying Shan; Lingya Pan
Journal:  J Cancer       Date:  2015-02-27       Impact factor: 4.207

2.  Macroscopic lymphovascular invasion visualized on mammogram and magnetic resonance imaging: Initially misidentified as ductal carcinoma in situ but properly diagnosed by immunohistochemistry.

Authors:  Linda M Sanders; Michael Dardik; Lopa Modi; Alison Esteva Sanders; Sarah S Schaefer; Anya Litvak
Journal:  SAGE Open Med Case Rep       Date:  2017-04-21

3.  Intra-tumoural lipid composition and lymphovascular invasion in breast cancer via non-invasive magnetic resonance spectroscopy.

Authors:  Sai Man Cheung; Ehab Husain; Vasiliki Mallikourti; Yazan Masannat; Steven Heys; Jiabao He
Journal:  Eur Radiol       Date:  2020-12-03       Impact factor: 5.315

4.  The "cavitary" type of angiogenesis by gastric cancer. Morphological characteristics and prognostic value.

Authors:  Marina Senchukova; Mikhail V Kiselevsky
Journal:  J Cancer       Date:  2014-03-20       Impact factor: 4.207

Review 5.  Lymphatic Endothelial Markers and Tumor Lymphangiogenesis Assessment in Human Breast Cancer.

Authors:  Jia-Mei Chen; Bo Luo; Ru Ma; Xi-Xi Luo; Yong-Shun Chen; Yan Li
Journal:  Diagnostics (Basel)       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.